Delayed Recognition of Levetiracetam-induced Pancytopenia
Department
Internal Medicine
Document Type
Article
Publication Title
European Journal of Case Reports in Internal Medicine
Abstract
Blood dyscrasias associated with levetiracetam use can be difficult to identify, especially when other potential differential diagnoses are concurrently present. Here we present a 57-year-old man with metastatic adenocarcinoma of unknown primary origin on levetiracetam who initially presented with an in-stent thrombosis of the right external iliac vein and then developed worsening thrombocytopenia followed by pancytopenia. Levetiracetam was not identified as the culprit until other causes like platelet consumption, heparin-induced thrombocytopenia, idiopathic immune thrombocytopenic purpura, and bone marrow involvement by metastatic disease were ruled out.
First Page
002449
DOI
10.12890/2021_002449
Volume
8
Issue
3
Publication Date
3-30-2021
PubMed ID
33869106
Recommended Citation
Ammad Ud Din, M., Ather Hussain, S., & Bodrog, A. (2021). Delayed Recognition of Levetiracetam-induced Pancytopenia. European Journal of Case Reports in Internal Medicine, 8 (3), 002449. https://doi.org/10.12890/2021_002449